Rivanna Medical’s Accuro receives FDA clearance: 4 observations

Rivanna Medical received FDA 510(k) clearance to market its Accuro device.

Advertisement

Here are four observations:

 

1. Accuro is a handheld and untethered smart phone-sized ultrasound device featuring automated 3D navigation technology.

 

2. The initial commercial application of the Accuro platform is helping clinicians with successful administration of spinal anesthesia.

 

3. The device is also designed for additional indications for ultrasound imaging of abdominal, cardiac and peripheral vascular anatomies.

 

4. Rivanna Medical is a privately held medical technology company that is commercializing its initial product, Accuro.

 

More articles on devices:
SpineGuard, K2M, Mazor Robotics & more — 19 key notes
5 things to know about BioStar Ventures netting $68.8 M for new VC Fund
NuVasive shares drop 1.1%: 5 quick facts

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.